Sabin-Aspen Vaccine Science and Policy Group Meeting
The Sabin-Aspen Vaccine Science & Policy Group convened influential, out-of-the-box thinkers across scientific, medical, business and regulatory disciplines to vigorously probe the urgent need to eliminate the persistent threat of influenza.
Following the meeting, the Group put forth its inaugural report advancing three actionable “Big Ideas” to accelerate a next-generation influenza vaccine.
The Sabin-Aspen Vaccine Science & Policy Group convened influential, out-of-the-box thinkers across scientific, medical, business and regulatory disciplines to vigorously probe a single topic each year and develop actionable recommendations. Meeting 100 years after the Spanish influenza epidemic that killed an estimated 50 million people worldwide, the group focused its first meeting on the urgent need for a next-generation vaccine to eliminate the persistent threat of influenza and posed bold recommendations for jump-starting the discovery and development of a universal influenza vaccine.
Following the meeting, the Group put forth its inaugural report stressing the urgency for a UIV and advancing the following “Big Ideas”:
- the creation of an entity to spearhead development of a UIV
- the advancement of a research and development agenda that actively seeks to broaden the range of scientific perspectives contributing to transformational changes in the pursuit of a licensed universal influenza vaccine
- the development and implementation of a communications strategy explicitly designed to reinforce the urgency of the global need for a universal influenza vaccine
Images from the Sabin-Aspen meeting
View photos from this convening of innovative thinkers determined to prevent the next influenza pandemic.
Accelerating Universal Influenza Vaccine Development
Read the group’s actionable recommendations for achieving a universal influenza vaccine.
